IKFE-Institute for Clinical Research and Development, Mainz, Germany.
Curr Med Res Opin. 2012 Jan;28(1):15-21. doi: 10.1185/03007995.2011.638911. Epub 2011 Nov 17.
Insulin-treated patients perform complex treatment activities during daily routine, such as blood glucose measurements and insulin injections. We aimed to identify suitable dexterity and cognitive function tests for diabetes patients, and to compare the patient self-assessment of their dexterity skills with the test results (Jebsen-Taylor hand function test, (JHFT), motoric performance test (MLS), number connection test).
We enrolled 90 diabetes patients (36 females, 54 males): 15 type 1 with clinically suspected dexterity impairment (A: age: 60 ± 9 years), 30 type 2 with clinically suspected dexterity impairment (B: 61 ± 10 years), 30 type 1 or type 2 patients with visual impairment (C: 64 ± 6 years), and 15 type 1 or type 2 patients without obvious impairment (control group: D: 64 ± 5 years).
There were no differences regarding neuropathy and slight impairments in the number connection test in all groups. Patient self-assessment revealed that 33.4% in group A, 33.3% in group B, 36.7% in group C and 13.7% in group D, considered themselves to have dexterity impairment. However in the JHFT test, all patients from A (100%) and B (100%), 33% from C, and 0% from D presented with dexterity impairment by only passing less than four subtests.
Impairment of dexterity was much more frequent than believed by the patients themselves. It may be worthwhile to consider these findings when classifying patients regarding their capabilities to perform certain treatments or when assessing diabetes technology with human subjects.
接受胰岛素治疗的患者在日常常规中进行复杂的治疗活动,如血糖测量和胰岛素注射。我们旨在确定适合糖尿病患者的灵巧性和认知功能测试,并将患者对自己灵巧技能的自我评估与测试结果(Jebsen-Taylor 手功能测试(JHFT)、运动表现测试(MLS)、数字连接测试)进行比较。
我们招募了 90 名糖尿病患者(36 名女性,54 名男性):15 名 1 型糖尿病患者(A 组:年龄:60±9 岁),有临床疑似灵巧障碍,30 名 2 型糖尿病患者(B 组:61±10 岁),有临床疑似灵巧障碍,30 名 1 型或 2 型糖尿病患者视力障碍(C 组:64±6 岁),和 15 名 1 型或 2 型糖尿病患者无明显障碍(对照组:D 组:64±5 岁)。
所有组在神经病和数字连接测试中都没有明显的轻微损伤。患者自我评估显示,A 组有 33.4%、B 组有 33.3%、C 组有 36.7%、D 组有 13.7%的患者认为自己有灵巧障碍。然而,在 JHFT 测试中,A 组(100%)和 B 组(100%)的所有患者、C 组的 33%患者和 D 组的 0%患者仅通过不到四个子测试就表现出灵巧障碍。
灵巧障碍的发生率远高于患者自身的认知。在对患者进行特定治疗能力分类或评估糖尿病技术的人体受试者时,考虑这些发现可能是值得的。